CSNK2B and epilepsy: CSNK2B causes Poirier-Bienvenu neurodevelopmental syndrome, which is characterized by early-onset epilepsy (median 5 months), clustered GTCS, myoclonic seizures, and DD (Bonanni et al., 2021).